BISvsIUSG
ProShares UltraShort Nasdaq Biotechnology against iShares Core S&P U.S. Growth ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BIS | IUSG | |
|---|---|---|
| Expense ratio | 0.95% | 0.040% |
| Assets | $1792.22T | $33.1B |
| Net flow, 1 month | — | +$526M |
| Net flow, 1 year | +$2K | +$3.3B |
| Return, YTD | -43.0% | +12.9% |
| Return, 1 year | -61.5% | +20.9% |
| Avg daily volume | 9K | 538K |
| Holdings | 7 | 480 |
| Listed | Apr 8, 2010 | Jul 23, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS